Comprehensive analysis of kinase inhibitor selectivity - PubMed (original) (raw)
. 2011 Oct 30;29(11):1046-51.
doi: 10.1038/nbt.1990.
Affiliations
- PMID: 22037378
- DOI: 10.1038/nbt.1990
Comprehensive analysis of kinase inhibitor selectivity
Mindy I Davis et al. Nat Biotechnol. 2011.
Abstract
We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome. Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend. The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compounds tested. Analysis of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily. The data set suggests compounds to use as tools to study kinases for which no dedicated inhibitors exist. It also provides a foundation for further exploring kinase inhibitor biology and toxicity, as well as for studying the structural basis of the observed interaction patterns. Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.
Comment in
- Interrogating the kinome.
Zhang C, Habets G, Bollag G. Zhang C, et al. Nat Biotechnol. 2011 Nov 8;29(11):981-3. doi: 10.1038/nbt.2021. Nat Biotechnol. 2011. PMID: 22068532 No abstract available.
Similar articles
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. Anastassiadis T, et al. Nat Biotechnol. 2011 Oct 30;29(11):1039-45. doi: 10.1038/nbt.2017. Nat Biotechnol. 2011. PMID: 22037377 Free PMC article. - Recent advances in designing substrate-competitive protein kinase inhibitors.
Han KC, Kim SY, Yang EG. Han KC, et al. Curr Pharm Des. 2012;18(20):2875-82. doi: 10.2174/138161212800672697. Curr Pharm Des. 2012. PMID: 22571656 Review. - Large-scale proteomics analysis of the human kinome.
Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Kéri G, Mann M, Daub H. Oppermann FS, et al. Mol Cell Proteomics. 2009 Jul;8(7):1751-64. doi: 10.1074/mcp.M800588-MCP200. Epub 2009 Apr 15. Mol Cell Proteomics. 2009. PMID: 19369195 Free PMC article. - Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach.
Brylinski M, Skolnick J. Brylinski M, et al. Mol Pharm. 2010 Dec 6;7(6):2324-33. doi: 10.1021/mp1002976. Epub 2010 Nov 8. Mol Pharm. 2010. PMID: 20958088 Free PMC article. - Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H. Daub H. ACS Chem Biol. 2015 Jan 16;10(1):201-12. doi: 10.1021/cb5008794. Epub 2014 Dec 17. ACS Chem Biol. 2015. PMID: 25474541 Review.
Cited by
- Impact of Optimized Ku-DNA Binding Inhibitors on the Cellular and In Vivo DNA Damage Response.
Mendoza-Munoz PL, Kushwaha ND, Chauhan D, Ali Gacem KB, Garrett JE, Dynlacht JR, Charbonnier JB, Gavande NS, Turchi JJ. Mendoza-Munoz PL, et al. Cancers (Basel). 2024 Sep 26;16(19):3286. doi: 10.3390/cancers16193286. Cancers (Basel). 2024. PMID: 39409907 Free PMC article. - Graph neural pre-training based drug-target affinity prediction.
Ye Q, Sun Y. Ye Q, et al. Front Genet. 2024 Sep 16;15:1452339. doi: 10.3389/fgene.2024.1452339. eCollection 2024. Front Genet. 2024. PMID: 39350770 Free PMC article. - Protein language models are performant in structure-free virtual screening.
Lam HYI, Guan JS, Ong XE, Pincket R, Mu Y. Lam HYI, et al. Brief Bioinform. 2024 Sep 23;25(6):bbae480. doi: 10.1093/bib/bbae480. Brief Bioinform. 2024. PMID: 39327890 Free PMC article. - Computationally Driven Discovery of a BCR-ABL1 Kinase Inhibitor with Activity in Multidrug-Resistant Chronic Myeloid Leukemia.
Hill J, Givhan RH, Yi B, Jones RM, Douglass EF, Xi Y, Schaefer HF 3rd, Crich D. Hill J, et al. J Med Chem. 2024 Oct 10;67(19):17820-17832. doi: 10.1021/acs.jmedchem.4c01852. Epub 2024 Sep 23. J Med Chem. 2024. PMID: 39311765 Free PMC article. - Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia.
Borek WE, Nobre L, Pedicona SF, Campbell AE, Christopher JA, Nawaz N, Perkins DN, Moreno-Cardoso P, Kelsall J, Ferguson HR, Patel B, Gallipoli P, Arruda A, Ambinder AJ, Thompson A, Williamson A, Ghiaur G, Minden MD, Gribben JG, Britton DJ, Cutillas PR, Dokal AD. Borek WE, et al. EBioMedicine. 2024 Oct;108:105316. doi: 10.1016/j.ebiom.2024.105316. Epub 2024 Sep 17. EBioMedicine. 2024. PMID: 39293215 Free PMC article.
References
- Biochem J. 2003 Apr 1;371(Pt 1):199-204 - PubMed
- Bioinformatics. 2010 Jan 15;26(2):198-204 - PubMed
- Nat Chem Biol. 2010 May;6(5):359-68 - PubMed
- Nat Chem Biol. 2006 Jul;2(7):358-64 - PubMed
- Nat Chem Biol. 2011 Apr;7(4):203-5 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases